Clinical Trial Update: Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial compared insulin detemir with insulin glargine in adults with type 2 diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED